Showing results (191-200 of 339) with videos related to
Sort By:
Pageof 34
Cytotherapy|August 6, 2016
Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis productsChristina Berens, Annkristin Heine, Jens Müller, et al.Urologia Internationalis|April 2, 2016
Primary Urethral Plasmacytoma Treated with High-Dose-Rate Brachytherapy: A Case ReportJohannes Stein, Stefan Latz, Jörg Ellinger, et al.International Journal of Molecular Sciences|September 1, 2019
Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CMLPeter Valent, Irina Sadovnik, Gregor Eisenwort, et al.Diabetes|September 14, 2011
Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathyKathrin Eller, Alexander Kirsch, Anna M Wolf, et al.Cardiovascular Research|July 27, 2019
Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistanceMariann Gyöngyösi, Dominika Lukovic, Katrin Zlabinger, et al.Current Oncology (Toronto, Ont.)|November 24, 2022
Multidisciplinary Treatment of Liver Metastases from Intracranial SFTs/HPCs: A Report of Three Consecutive CasesFelix J Krendl, Franka Messner, Gregor Laimer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancerDominik Wolf, Anna M Wolf, Holger Rumpold, et al.Cancer Medicine|May 11, 2021
The cancer patient's perspective of COVID-19-induced distress-A cross-sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemicKarin A Koinig, Christoph Arnold, Jens Lehmann, et al.Immunology and Cell Biology|March 9, 2011
Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccineChristina Lutz-Nicoladoni, Stephanie Wallner, Patrizia Stoitzner, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2009
The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivoAnna Maria Wolf, Kathrin Eller, Robert Zeiser, et al.Pageof 34